FDA Public Meeting on Enhanced Drug Distribution Security under DSCSA
“Patient safety is at the core of FDA’s public health mission; and ensuring reliable patient access to safe and effective medicines requires maintaining a closed, secure U.S. drug supply chain for the distribution and delivery of finished drug products” said Scott Gottlieb on February 28, 2018 at FDA Public Meeting…